Intake of blood pressure pills could increase the risk of potentially deadly appendicitis by up to 63 per cent, a new study has found.
Types of blood pressure pill like ACE inhibitors and ARBs raised the risk considerably in millions of people.
The two types can cause swelling in the bowel which inflames the appendix - a vestigial finger-like pouch connected to the large intestine, ‘The Sun’ reported.
When this occurs, it must be removed within hours or a deadly infection can set in. Around 300,000 men and women were studied at the Beth Deaconess Hospital, Boston, US.
Researchers discovered ACEs and ARBs appeared to increase the chance of appendix trouble by 36 to 63 per cent. Generic drug names for ACEs include ramipril, lisinopril and perindopril.
ARBs include telmisartan, losartan and candesartan, the paper reported.
None of the other blood pressure tablets, like beta-blockers or calcium-channel blockers, had the same effect.
The National Health Service (NHS) in UK issues more than 50 million prescriptions for the pills each year. The drugs work by keeping the arteries open, boosting blood flow.
“It’s vital people continue to take their medication and discuss their individual risk, if any, with their doctor,” the British Heart Foundation said.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
Please Email the Editor